CVS Health Corporation (NYSE:CVS) will release earnings results for the second quarter before the opening bell on Thursday, July 31.
Analysts expect the Woonsocket, Rhode Island-based company to report quarterly earnings at $1.46 per share, down from $1.83 per share in the year-ago period. CVS Health is projected to report quarterly revenue of $94.59 billion, compared to $91.23 billion a year earlier, according to data from Benzinga Pro.
On July 23, CVS Health announced the opening of its new Workforce Innovation and Talent Center (WITC) in Columbus.
CVS Health shares gained 3.8% to close at $62.30 on Wednesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
- UBS analyst Kevin Caliendo maintained a Neutral rating and cut the price target from $71 to $67 on July 22, 2025. This analyst has an accuracy rate of 70%.
- Jefferies analyst Brian Tanquilut maintained a Buy rating and raised the price target from $74 to $80 on June 30, 2025. This analyst has an accuracy rate of 64%.
- Mizuho analyst Ann Hynes maintained an Outperform rating and increased the price target from $70 to $76 on April 9, 2025. This analyst has an accuracy rate of 85%.
- Leerink Partners analyst Michael Cherny upgraded the stock from Market Perform to Outperform and raised the price target from $55 to $75 on Feb. 13, 2025. This analyst has an accuracy rate of 79%.
Considering buying CVS stock? Here’s what analysts think:
Read This Next:
Photo via Shutterstock
